Related Experiment Video
Updated: Jun 10, 2025

09:45
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.5K
Rationally designed porous self-assembled nanoparticles for combinational chemo-photodynamic therapy
Kanchan Negi1, Ashok Kumar1, Gourav Chakraborty1
1Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM), Dhanbad 826004, Jharkhand, India. sumantchem@gmail.com.
Dalton Transactions (Cambridge, England : 2003)
|October 15, 2024
Summary
Researchers developed rapid, zinc-coordinated quercetin nanoparticles (ZnQ NPs) for dual-mode cancer therapy. This novel chemo-PDT approach enhances drug delivery and shows significant potential for improved cancer treatment outcomes.
Area of Science:
- Nanomedicine
- Materials Science
- Biochemistry
Background:
- Cancer remains a significant global health challenge despite therapeutic advancements.
- Combinational therapies, like chemotherapy and photodynamic therapy (chemo-PDT), offer promising strategies.
- Developing efficient drug delivery systems is crucial for enhancing treatment efficacy.
Purpose of the Study:
- To develop novel zinc-coordinated quercetin-based nanoparticles (ZnQ NPs) for dual-mode cancer therapy.
- To create a rapid, single-step synthesis method for these advanced nanoparticles.
- To investigate the therapeutic potential of ZnQ NPs loaded with photosensitizers for enhanced cancer treatment.
Main Methods:
- Synthesized zinc-coordinated quercetin-based nanoparticles (ZnQ NPs) in a 15-minute single-step process.
- Utilized Density Functional Theory (DFT) calculations to determine optimal binding configurations and band gaps.
- Loaded chlorin e6 (Ce6) photosensitizer into ZnQ NPs via hydrophobic interactions, creating ZnQ@Ce6 nanocomposites.
Main Results:
- Achieved rapid synthesis of pH-responsive, water-dispersible, stable, and biocompatible ZnQ NPs.
- Demonstrated high Ce6 loading capacity (19.03%) within the ZnQ@Ce6 nanocomposite.
- Observed a significant cell inhibition rate of 77% under specific light conditions, indicating enhanced therapeutic effects.
Conclusions:
- ZnQ NPs represent a novel, efficient platform for dual-mode chemo-PDT cancer therapy.
- This dual-functional platform enhances the solubility and bioavailability of photosensitizers like Ce6.
- The developed ZnQ@Ce6 nanocomposite shows significant potential for improving clinical nanomedicine and cancer treatment outcomes.

